Company Profile

HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE2352.00-10 (-0.42 % )
PREV CLOSE (Rs.) 2362.00
OPEN PRICE (Rs.) 2373.70
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 55
TODAY'S LOW / HIGH (Rs.)2352.00 2389.00
52 WK LOW / HIGH (Rs.)1600 3180
NSE2373.35 4.9 (+0.21 % )
PREV CLOSE(Rs.) 2368.45
OPEN PRICE (Rs.) 2365.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 8525
TODAY'S LOW / HIGH(Rs.) 2352.05 2392.00
52 WK LOW / HIGH (Rs.)1601 3134

Financial ratio

Particulars Mar  2021 Mar  2020 Mar  2019 Mar  2018 Mar  2017
Operational & Financial Ratios          
   Earnings Per Share (Rs) 40.47 34.29 48.86 30.12 27.68
   CEPS(Rs) 56.44 51.81 61.65 38.47 35.02
   DPS(Rs) 10.00 6.60 11.00 10.00 5.30
   Book NAV/Share(Rs) 268.38 236.36 208.61 165.32 143.35
   Tax Rate(%) 30.75 24.98 28.43 36.14 26.34
Margin Ratios          
   Core EBITDA Margin(%) 32.03 30.23 38.21 34.65 32.71
   EBIT Margin(%) 26.46 26.57 35.66 29.44 27.46
   Pre Tax Margin(%) 23.38 22.55 31.93 26.48 24.67
   PAT Margin (%) 16.19 16.92 22.85 16.91 18.17
   Cash Profit Margin (%) 22.40 24.05 29.45 23.99 23.75
Performance Ratios          
   ROA(%) 8.70 9.04 14.97 10.10 11.43
   ROE(%) 16.16 16.38 25.59 17.57 20.38
   ROCE(%) 17.33 16.53 26.64 20.20 19.75
   Asset Turnover(x) 0.54 0.53 0.66 0.60 0.63
   Sales/Fixed Asset(x) 0.94 0.83 0.92 0.84 0.96
   Working Capital/Sales(x) 2.14 2.42 1.91 3.11 2.99
Efficiency Ratios          
   Fixed Capital/Sales(x) 1.06 1.21 1.08 1.18 1.04
   Receivable days 91.66 90.92 66.77 78.70 76.80
   Inventory Days 107.45 114.27 92.80 97.89 97.55
   Payable days 60.64 42.10 27.25 33.70 33.48
Valuation Parameters          
   PER(x) 47.36 26.98 31.62 53.25 27.57
   PCE(x) 33.96 17.85 25.06 41.69 21.79
   Price/Book(x) 7.14 3.91 7.41 9.70 5.32
   Yield(%) 0.52 0.71 0.71 0.62 0.69
   EV/Net Sales(x) 8.00 4.82 7.66 10.44 5.72
   EV/Core EBITDA(x) 23.37 14.31 18.12 28.50 16.99
   EV/EBIT(x) 30.22 18.16 21.47 35.36 20.44
   EV/CE(x) 4.17 2.29 4.55 5.82 3.31
   M Cap / Sales 7.61 4.29 7.38 10.04 5.27
Growth Ratio          
   Net Sales Growth(%) 16.95 2.92 30.99 10.42 22.02
   Core EBITDA Growth(%) 18.74 -17.91 51.04 20.23 20.88
   EBIT Growth(%) 16.45 -23.30 58.10 16.63 20.70
   PAT Growth(%) 11.92 -23.82 76.41 1.23 18.80
   EPS Growth(%) 18.03 -29.83 62.24 8.81 22.66
Financial Stability Ratios          
   Total Debt/Equity(x) 0.46 0.60 0.51 0.49 0.54
   Current Ratio(x) 2.63 1.91 2.91 1.80 2.10
   Quick Ratio(x) 1.62 1.14 1.87 1.07 1.22
   Interest Cover(x) 8.59 6.61 9.57 9.95 9.84
   Total Debt/Mcap(x) 0.06 0.15 0.07 0.05 0.10